Clinical Trial Detail

NCT ID NCT02875613
Title Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Assuntina Sacco, M.D.
Indications

nasopharynx carcinoma

Therapies

Avelumab

Age Groups: adult

No variant requirements are available.